With 2.0 million shares changed hands, the volume of the stock remained lighter than its average volume of 3.28 million shares. The 52-week range on XRAY shows that it touched its highest point at $28.25 and its lowest point at $12.16 during that stretch. It currently has a 1-year price target of $17.96. With its current market cap of 3.11 billion, XRAY has annualized dividend of $0.64 while the current yield stands at 4.10%. Beta for the stock currently stands at 0.96.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of XRAY was up-trending over the past week, with a rise of 0.97%, but this was up by 12.13% over a month. Three-month performance dropped to -2.31% while six-month performance fell -18.60%. The stock lost -42.40% in the past year, while it has lost -17.70% so far this year. A look at the trailing 12-month EPS for XRAY yields -4.54 with Next year EPS estimates of 2.05. For the next quarter, that number is 0.50. This implies an EPS growth rate of 13.38% for this year and 8.18% for next year.
Float and Shares Shorts:
At present, 199.30 million XRAY shares are outstanding with a float of 197.81 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for XRAY since 3 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $1.85494 being high and $1.81504 being low. For XRAY, this leads to a yearly average estimate of $1.83499. Based on analyst estimates, the high estimate for the next quarter is $0.49 and the low estimate is $0.42. The average estimate for the next quarter is thus $0.46.
